Evidence map›Paper›PMID 36094194›Full record

ArticleMicrobiology spectrum2022

Physiological, Biochemical, and Structural Bioinformatic Analysis of the Multiple Inositol Dehydrogenases from Corynebacterium glutamicum.

Paul Ramp, Christopher Pfleger, Jonas Dittrich, Christina Mack, Holger Gohlke, Michael Bott

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Growth ofApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Efficient pathway-drivenApplied and environmental microbiology · 2024
    Article
  5. Article
  6. ABeilstein journal of organic chemistry · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paul RampIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülichgrid.8385.6, Jülich, Germany.ORCID 0000-0002-4228-5337
Christopher PflegerInstitut für Pharmazeutische und Medizinische Chemie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-5524-6978
Jonas DittrichThe Bioeconomy Science Center (BioSC), Forschungszentrum Jülichgrid.8385.6, Jülich, Germany.ORCID 0000-0003-2377-2268
Christina MackIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülichgrid.8385.6, Jülich, Germany.
Holger GohlkeThe Bioeconomy Science Center (BioSC), Forschungszentrum Jülichgrid.8385.6, Jülich, Germany.ORCID 0000-0001-8613-1447
Michael BottIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülichgrid.8385.6, Jülich, Germany.ORCID 0000-0002-4701-8254
Forschungszentrum Jülich · DEHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inositols (cyclohexanehexols) comprise nine isomeric cyclic sugar alcohols, several of which occur in all domains of life with various functions. Many bacteria can utilize inositols as carbon and energy sources via a specific pathway involving inositol dehydrogenases (IDHs) as the first step of catabolism. The microbial cell factory Corynebacterium glutamicum can grow with

Indexed as

Corynebacterium glutamicumDiabetes Mellitus, Type 2CarbonComputational BiologyInositolMolecular Docking SimulationNADOxidoreductasesSoilCarbonInositolNADOxidoreductasesscyllitolSoilCorynebacterium glutamicumd-chiro-inositolenzyme kineticsinositol dehydrogenaseinositol metabolisminositolsmolecular dockingmyo-inositolscyllo-inositolstructural models

Identifiers

PMID36094194
PMCPMC9603128
OpenAlexW4295280491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.